Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date

Por weekers, LE, Campistol, JM, Espinosa, M, Gaber, AO, Menne, J, Minetti, E, Provot, F, Rondeau, E, Ogawa, M, Bedrosian, CL, hourmant, M
Publicado em 2014

Elevated soluble Flt1 mediates an anti-angiogenic state in patients with ANCA-associated vasculitis

Por Le Roux, S, Pepper, R, Dufay, A, Néel, M, Lamandé, N, Rimbert, M, Josien, R, Hamidou, M, Hourmant, M, Cook, H T, Charreau, B, Larger, E, Salama, A, Fakhouri, F
Publicado em 2010